At the end of the latest market close, BriaCell Therapeutics Corp. (BCTX) was valued at $3.46. In that particular session, Stock kicked-off at the price of $3.49 while reaching the peak value of $3.95 and lowest value recorded on the day was $3.36. The stock current value is $3.69.
Recently in News on April 21, 2021, BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com. SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Bill Williams, M.D., President and CEO of BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX-V: BCT) (“the Company”), to discuss the Company’s targeted immunotherapies for breast cancer and its unique position as a clinical-stage biotech company. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
BriaCell Therapeutics Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.35 on 02/22/21, with the lowest value was $2.81 for the same time period, recorded on 04/20/21.
BriaCell Therapeutics Corp. (BCTX) full year performance was -69.25%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BriaCell Therapeutics Corp. shares are logging -52.74% during the 52-week period from high price, and 31.09% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.81 and $7.81.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3979669 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BriaCell Therapeutics Corp. (BCTX) recorded performance in the market was -11.51%, having the revenues showcasing -32.91% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 24.71M.
The Analysts eye on BriaCell Therapeutics Corp. (BCTX)
During the last month, 0 analysts gave the BriaCell Therapeutics Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.05, with a change in the price was noted -0.62. In a similar fashion, BriaCell Therapeutics Corp. posted a movement of -14.42% for the period of last 100 days, recording 648,031 in trading volumes.
Technical rundown of BriaCell Therapeutics Corp. (BCTX)
Raw Stochastic average of BriaCell Therapeutics Corp. in the period of last 50 days is set at 24.76%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 34.52%. In the last 20 days, the company’s Stochastic %K was 30.77% and its Stochastic %D was recorded 29.22%.
Considering, the past performance of BriaCell Therapeutics Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -11.51%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -9.11%, alongside a downfall of -69.25% for the period of the last 12 months. The shares increased approximately by 12.50% in the 7-day charts and went up by -4.40% in the period of the last 30 days. Common stock shares were lifted by -32.91% during last recorded quarter.